Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Medtronic
Colorcon
Boehringer Ingelheim

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Affinion Net Patents Inc. v. Maritz Inc. (D. Del. 2004)

See Plans and Pricing

« Back to Dashboard

Affinion Net Patents Inc. v. Maritz Inc. (D. Del. 2004)

Docket   Start Trial Date Filed 2004-06-08
Court District Court, D. Delaware Date Terminated 2007-01-22
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Plaintiff Referred To
Parties AFFINION NET PATENTS INC.; MARITZ INC.
Patents 10,086,010; 9,598,486
Attorneys Benjamin J. Schladweiler; Jack B. Blumenfeld; Maryellen Noreika; Patricia Smink Rogowski; Paul E. Crawford; Rudolf E. Hutz
Firms Morris, Nichols, Arsht & Tunnell; Novak Druce Connolly Bove Quigg LLP, the Nemours Building; Seitz Ross Aronstam & Moritz LLP
Link to Docket External link to docket
Biologic Drugs cited in Affinion Net Patents Inc. v. Maritz Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Affinion Net Patents Inc. v. Maritz Inc. (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2006-06-06 171 Exhibit A-B Document 171-2 Filed 06/06/2006 Page 20 of 22 1@;06 10:86 10:06 10:05 10:06 10:06 13:06 10:06 1010? 10:0? lG…fundamental to my patent, the ’870 patent, and which is not reflected in any part of the *4&4 patent, is the…we teik im the 'B?O patent about fully integrated. If you go to the patent ’B?C, end you look at the…which is reflected in the '373 patent, and not in the ’444 patent, that you could integrate in an internat…COURT FGR THE DlSTRiCT GF DELAWARE AFFINION NET PATENTS, lNC., ) l Plaintiff, ) Civil A.ction No. 04~360 External link to document
2005-09-29 64 Answer to Counterclaim . Trilegiant admits that U.S. Patent Application No. 09/598,486 contains two pending and unallowed…that the Cohen patent was not submitted to the PTO during the prosecution of the ‘870 patent and was submitted…that the Cohen patent was not submitted to the PTO during the prosecution of the ‘412 patent and was submitted…priority to the specification of the ‘444 patent. U.S. Patent Application No. 09/598,586 is a continuation…Page 6 of 12 Patent Application No. 08/892,563, which is a continuation of U.S. Patent Application No External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Express Scripts
McKinsey
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.